ArticlePloS one2012

Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA.

Yu Ming Paul Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.